Tag: Obesity
Tirzepatide Serves Up Major Weight-Loss Win in Patients With Obesity
The combination GIP and GLP-1 receptor agonist tirzepatide (Mounjaro) could soon be the next new treatment option for people with overweight or obesity, researchers reported. In the 72-week, phase III SURMOUNT-1 clinical trial, people with obesity, but without diabetes, on 15 mg of the once-weekly injectable had a mean percentage change in weight of -20.9%
Doctors schooled to shed anti-fat bias, look beyond obesity
When Melissa Boughton complained to her OB-GYN about dull pelvic pain, the doctor responded by asking about her diet and exercise habits. The question seemed irrelevant, considering the type of pain she was having, Boughton thought at the time. But it wasn’t unusual coming from this doctor. “Every time I was in there, she’d talk
Tirzepatide Once Weekly for the Treatment of Obesity
Abstract Background Obesity is a chronic disease that results in substantial global morbidity and mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, in people with obesity are not known. Methods In this phase 3 double-blind, randomized, controlled trial, we assigned 2539 adults with a body-mass index
Obesity Raises a Woman’s Odds for Broken Bones | Health and Fitness
Robert Preidt MONDAY, May 9, 2022 (HealthDay News) — Being overweight or obese is never good for one’s health, but now a new study suggests it increases a woman’s risk of broken bones. For the study, researchers followed 20,000 women and men, aged 40 to 70, in the Canadian province of Quebec from 2009 until